Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer

Zipeng Zhen, Wei Tang, Cunlan Guo, Hongmin Chen, Xin Lin, Gang Liu, Baowei Fei, Xiaoyuan Chen, Binqian Xu, Jin Xie

Research output: Contribution to journalArticle

156 Citations (Scopus)

Abstract

Photodynamic therapy is an emerging treatment modality that is under intensive preclinical and clinical investigations for many types of disease including cancer. Despite the promise, there is a lack of a reliable drug delivery vehicle that can transport photosensitizers (PSs) to tumors in a site-specific manner. Previous efforts have been focused on polymer- or liposome-based nanocarriers, which are usually associated with a suboptimal PS loading rate and a large particle size. We report herein that a RGD4C-modified ferritin (RFRT), a protein-based nanoparticle, can serve as a safe and efficient PS vehicle. Zinc hexadecafluorophthalocyanine (ZnF16Pc), a potent PS with a high 1O2 quantum yield but poor water solubility, can be encapsulated into RFRTs with a loading rate as high as ∼60 wt % (i.e., 1.5 mg of ZnF16Pc can be loaded on 1 mg of RFRTs), which far exceeds those reported previously. Despite the high loading, the ZnF 16Pc-loaded RFRTs (P-RFRTs) show an overall particle size of 18.6 ± 2.6 nm, which is significantly smaller than other PS-nanocarrier conjugates. When tested on U87MG subcutaneous tumor models, P-RFRTs showed a high tumor accumulation rate (tumor-to-normal tissue ratio of 26.82 ± 4.07 at 24 h), a good tumor inhibition rate (83.64% on day 12), as well as minimal toxicity to the skin and other major organs. This technology can be extended to deliver other metal-containing PSs and holds great clinical translation potential.

Original languageEnglish (US)
Pages (from-to)6988-6996
Number of pages9
JournalACS Nano
Volume7
Issue number8
DOIs
StatePublished - Aug 27 2013
Externally publishedYes

Fingerprint

Photodynamic therapy
Photosensitizing Agents
Photosensitizers
Ferritins
therapy
tumors
cancer
Tumors
loading rate
vehicles
Particle size
Liposomes
toxicity
organs
Quantum yield
emerging
delivery
Drug delivery
drugs
solubility

Keywords

  • ferritin
  • nanoparticle
  • photodynamic therapy
  • photosensitizer
  • targeted delivery

ASJC Scopus subject areas

  • Materials Science(all)
  • Engineering(all)
  • Physics and Astronomy(all)

Cite this

Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer. / Zhen, Zipeng; Tang, Wei; Guo, Cunlan; Chen, Hongmin; Lin, Xin; Liu, Gang; Fei, Baowei; Chen, Xiaoyuan; Xu, Binqian; Xie, Jin.

In: ACS Nano, Vol. 7, No. 8, 27.08.2013, p. 6988-6996.

Research output: Contribution to journalArticle

Zhen, Z, Tang, W, Guo, C, Chen, H, Lin, X, Liu, G, Fei, B, Chen, X, Xu, B & Xie, J 2013, 'Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer', ACS Nano, vol. 7, no. 8, pp. 6988-6996. https://doi.org/10.1021/nn402199g
Zhen, Zipeng ; Tang, Wei ; Guo, Cunlan ; Chen, Hongmin ; Lin, Xin ; Liu, Gang ; Fei, Baowei ; Chen, Xiaoyuan ; Xu, Binqian ; Xie, Jin. / Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer. In: ACS Nano. 2013 ; Vol. 7, No. 8. pp. 6988-6996.
@article{ba5066edba294b89894531215ada50c3,
title = "Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer",
abstract = "Photodynamic therapy is an emerging treatment modality that is under intensive preclinical and clinical investigations for many types of disease including cancer. Despite the promise, there is a lack of a reliable drug delivery vehicle that can transport photosensitizers (PSs) to tumors in a site-specific manner. Previous efforts have been focused on polymer- or liposome-based nanocarriers, which are usually associated with a suboptimal PS loading rate and a large particle size. We report herein that a RGD4C-modified ferritin (RFRT), a protein-based nanoparticle, can serve as a safe and efficient PS vehicle. Zinc hexadecafluorophthalocyanine (ZnF16Pc), a potent PS with a high 1O2 quantum yield but poor water solubility, can be encapsulated into RFRTs with a loading rate as high as ∼60 wt {\%} (i.e., 1.5 mg of ZnF16Pc can be loaded on 1 mg of RFRTs), which far exceeds those reported previously. Despite the high loading, the ZnF 16Pc-loaded RFRTs (P-RFRTs) show an overall particle size of 18.6 ± 2.6 nm, which is significantly smaller than other PS-nanocarrier conjugates. When tested on U87MG subcutaneous tumor models, P-RFRTs showed a high tumor accumulation rate (tumor-to-normal tissue ratio of 26.82 ± 4.07 at 24 h), a good tumor inhibition rate (83.64{\%} on day 12), as well as minimal toxicity to the skin and other major organs. This technology can be extended to deliver other metal-containing PSs and holds great clinical translation potential.",
keywords = "ferritin, nanoparticle, photodynamic therapy, photosensitizer, targeted delivery",
author = "Zipeng Zhen and Wei Tang and Cunlan Guo and Hongmin Chen and Xin Lin and Gang Liu and Baowei Fei and Xiaoyuan Chen and Binqian Xu and Jin Xie",
year = "2013",
month = "8",
day = "27",
doi = "10.1021/nn402199g",
language = "English (US)",
volume = "7",
pages = "6988--6996",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer

AU - Zhen, Zipeng

AU - Tang, Wei

AU - Guo, Cunlan

AU - Chen, Hongmin

AU - Lin, Xin

AU - Liu, Gang

AU - Fei, Baowei

AU - Chen, Xiaoyuan

AU - Xu, Binqian

AU - Xie, Jin

PY - 2013/8/27

Y1 - 2013/8/27

N2 - Photodynamic therapy is an emerging treatment modality that is under intensive preclinical and clinical investigations for many types of disease including cancer. Despite the promise, there is a lack of a reliable drug delivery vehicle that can transport photosensitizers (PSs) to tumors in a site-specific manner. Previous efforts have been focused on polymer- or liposome-based nanocarriers, which are usually associated with a suboptimal PS loading rate and a large particle size. We report herein that a RGD4C-modified ferritin (RFRT), a protein-based nanoparticle, can serve as a safe and efficient PS vehicle. Zinc hexadecafluorophthalocyanine (ZnF16Pc), a potent PS with a high 1O2 quantum yield but poor water solubility, can be encapsulated into RFRTs with a loading rate as high as ∼60 wt % (i.e., 1.5 mg of ZnF16Pc can be loaded on 1 mg of RFRTs), which far exceeds those reported previously. Despite the high loading, the ZnF 16Pc-loaded RFRTs (P-RFRTs) show an overall particle size of 18.6 ± 2.6 nm, which is significantly smaller than other PS-nanocarrier conjugates. When tested on U87MG subcutaneous tumor models, P-RFRTs showed a high tumor accumulation rate (tumor-to-normal tissue ratio of 26.82 ± 4.07 at 24 h), a good tumor inhibition rate (83.64% on day 12), as well as minimal toxicity to the skin and other major organs. This technology can be extended to deliver other metal-containing PSs and holds great clinical translation potential.

AB - Photodynamic therapy is an emerging treatment modality that is under intensive preclinical and clinical investigations for many types of disease including cancer. Despite the promise, there is a lack of a reliable drug delivery vehicle that can transport photosensitizers (PSs) to tumors in a site-specific manner. Previous efforts have been focused on polymer- or liposome-based nanocarriers, which are usually associated with a suboptimal PS loading rate and a large particle size. We report herein that a RGD4C-modified ferritin (RFRT), a protein-based nanoparticle, can serve as a safe and efficient PS vehicle. Zinc hexadecafluorophthalocyanine (ZnF16Pc), a potent PS with a high 1O2 quantum yield but poor water solubility, can be encapsulated into RFRTs with a loading rate as high as ∼60 wt % (i.e., 1.5 mg of ZnF16Pc can be loaded on 1 mg of RFRTs), which far exceeds those reported previously. Despite the high loading, the ZnF 16Pc-loaded RFRTs (P-RFRTs) show an overall particle size of 18.6 ± 2.6 nm, which is significantly smaller than other PS-nanocarrier conjugates. When tested on U87MG subcutaneous tumor models, P-RFRTs showed a high tumor accumulation rate (tumor-to-normal tissue ratio of 26.82 ± 4.07 at 24 h), a good tumor inhibition rate (83.64% on day 12), as well as minimal toxicity to the skin and other major organs. This technology can be extended to deliver other metal-containing PSs and holds great clinical translation potential.

KW - ferritin

KW - nanoparticle

KW - photodynamic therapy

KW - photosensitizer

KW - targeted delivery

UR - http://www.scopus.com/inward/record.url?scp=84883215535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883215535&partnerID=8YFLogxK

U2 - 10.1021/nn402199g

DO - 10.1021/nn402199g

M3 - Article

C2 - 23829542

AN - SCOPUS:84883215535

VL - 7

SP - 6988

EP - 6996

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 8

ER -